Article Details
Retrieved on: 2023-11-07 20:22:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Precigen Inc.'s agreement to pay investors $13 million to settle class claims that it misrepresented progress in a synthetic biology program ...
Article found on: news.bloomberglaw.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here